Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Ference

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Plos One|January 5, 2012
A common KIF6 polymorphism increases vulnerability to low-density lipoprotein cholesterol: two meta-analyses and a meta-regression analysisBrian A Ference, Wonsuk Yoo, John M Flack, et al.
JAMA|July 28, 2020
Lipids and Lipoproteins in 2020Brian A Ference, John J P Kastelein, Alberico L Catapano
Critical Pathways in Cardiology|July 26, 2014
Utility of Framingham risk score in urban emergency department patients with asymptomatic hypertensionAaron M Brody, John M Flack, Brian A Ference, et al.
Journal of the American College of Cardiology|March 16, 2015
Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization studyBrian A Ference, Faisal Majeed, Raju Penumetcha, et al.
Cardiovascular Research|December 1, 2023
Exploring apolipoprotein C-III: pathophysiological and pharmacological relevanceChris J Packard, Angela Pirillo, Sotirios Tsimikas, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 6, 2012
Relationship of resistant hypertension and treatment outcomes with total arterial compliance in a predominantly African American hypertensive cohortOmid Bakhtar, Brian A Ference, Lowell A Hedquist, et al.
Nature Reviews. Cardiology|March 12, 2021
Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug developmentMichael V Holmes, Tom G Richardson, Brian A Ference, et al.
Pharmacoeconomics|August 25, 2022
Integrating the Biology of Cardiovascular Disease into the Epidemiology of Economic Decision Modelling via Mendelian RandomisationZanfina Ademi, Jedidiah I Morton, Danny Liew, et al.
Journal of Clinical Lipidology|September 26, 2017
Genetic effects on efficacy of lipid-lowering drugsWilliam Virgil Brown, Alan S Brown, Brian A Ference, et al.
Hypertension (Dallas, Tex. : 1979)|March 5, 2014
Clinical effect of naturally random allocation to lower systolic blood pressure beginning before the development of hypertensionBrian A Ference, Stevo Julius, Nitin Mahajan, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Plos One|January 5, 2012
A common KIF6 polymorphism increases vulnerability to low-density lipoprotein cholesterol: two meta-analyses and a meta-regression analysisBrian A Ference, Wonsuk Yoo, John M Flack, et al.
JAMA|July 28, 2020
Lipids and Lipoproteins in 2020Brian A Ference, John J P Kastelein, Alberico L Catapano
Critical Pathways in Cardiology|July 26, 2014
Utility of Framingham risk score in urban emergency department patients with asymptomatic hypertensionAaron M Brody, John M Flack, Brian A Ference, et al.
Journal of the American College of Cardiology|March 16, 2015
Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization studyBrian A Ference, Faisal Majeed, Raju Penumetcha, et al.
Cardiovascular Research|December 1, 2023
Exploring apolipoprotein C-III: pathophysiological and pharmacological relevanceChris J Packard, Angela Pirillo, Sotirios Tsimikas, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 6, 2012
Relationship of resistant hypertension and treatment outcomes with total arterial compliance in a predominantly African American hypertensive cohortOmid Bakhtar, Brian A Ference, Lowell A Hedquist, et al.
Nature Reviews. Cardiology|March 12, 2021
Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug developmentMichael V Holmes, Tom G Richardson, Brian A Ference, et al.
Pharmacoeconomics|August 25, 2022
Integrating the Biology of Cardiovascular Disease into the Epidemiology of Economic Decision Modelling via Mendelian RandomisationZanfina Ademi, Jedidiah I Morton, Danny Liew, et al.
Journal of Clinical Lipidology|September 26, 2017
Genetic effects on efficacy of lipid-lowering drugsWilliam Virgil Brown, Alan S Brown, Brian A Ference, et al.
Hypertension (Dallas, Tex. : 1979)|March 5, 2014
Clinical effect of naturally random allocation to lower systolic blood pressure beginning before the development of hypertensionBrian A Ference, Stevo Julius, Nitin Mahajan, et al.
Pageof 7